LiteFold/IEDB huggingface dataset:
Reference: F Ebstein; K Textoris-Taube; C Keller; R Golnik; N Vigneron; B J Van den Eynde; B Schuler-Thurner; D Schadendorf; F K M Lorenz; W Uckert; S Urban; A Lehmann; N Albrecht-Koepke; K Janek; P Henklein; A Niewienda; P M Kloetzel; M Mishto. "Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes." Scientific reports (2016).

Epitope: gp100<sup>mel</sup><sub>47–52/40–42</sub>
Chemical type: Spliced peptide from proteins
Position: 47-52
Source molecule (GenBank): F8VXH8.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: gp100<sup>mel</sup><sub>47–52/40–42</sub>
Chemical type: Spliced peptide from proteins
Position: 47-52
Source molecule (GenBank): F8VXH8.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: gp100<sup>mel</sup><sub>47–52/40–42</sub>
Chemical type: Spliced peptide from proteins
Position: 47-52
Source molecule (GenBank): F8VXH8.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: gp100<sup>mel</sup><sub>47–52/40–42</sub>
Chemical type: Spliced peptide from proteins
Position: 47-52
Source molecule (GenBank): F8VXH8.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: gp100<sup>mel</sup><sub>47–52/40–42</sub>
Chemical type: Spliced peptide from proteins
Position: 47-52
Source molecule (GenBank): F8VXH8.1
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: gp100<sup>mel</sup><sub>47–52/40–42</sub>
Chemical type: Spliced peptide from proteins
Position: 47-52
Source molecule (GenBank): F8VXH8.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: gp100<sup>mel</sup><sub>47–52/40–42</sub>
Chemical type: Spliced peptide from proteins
Position: 47-52
Source molecule (GenBank): F8VXH8.1
Assay category: MhcBinding
Result: Positive

Epitope: gp100<sup>mel</sup><sub>195–202/192</sub>
Chemical type: Spliced peptide from proteins
Position: 195-202
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: gp100<sup>mel</sup><sub>195–202/192</sub>
Chemical type: Spliced peptide from proteins
Position: 195-202
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Mesha Saeed; Mandy van Brakel; Sara Zalba; Erik Schooten; Joost A P Rens; Gerben A Koning; Reno Debets; Timo L M Ten Hagen. "Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody." International journal of nanomedicine (2016).

Epitope: MAGE A1 peptide
Chemical type: Peptide from protein
Sequence: EADPTGHSY
Position: 161-169
Source molecule (GenBank): P43355.1
Assay category: BCell
Result: Positive

Epitope: MAGE A1 peptide
Chemical type: Peptide from protein
Sequence: EADPTGHSY
Position: 161-169
Source molecule (GenBank): P43355.1
Assay category: BCell
Result: Positive

Epitope: MAGE A1 peptide
Chemical type: Peptide from protein
Sequence: EADPTGHSY
Position: 161-169
Source molecule (GenBank): P43355.1
Assay category: BCell
Result: Positive
Reference: Frédéric Ebstein; Martin Keller; Annette Paschen; Peter Walden; Michael Seeger; Elke Bürger; Elke Krüger; Dirk Schadendorf; Peter-M Kloetzel; Ulrike Seifert. "Exposure to Melan-A/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS)." Scientific reports (2016).

Epitope: Melan-A / MART-1<sub>26-35M</sub>
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: Melan-A / MART-1<sub>26-35M</sub>
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: Melan-A / MART-1<sub>26-35M</sub>
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: Melan-A / MART-1<sub>26-35M</sub>
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: Melan-A / MART-1<sub>26-35M</sub>
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: Melan-A / MART-1<sub>26-35M</sub>
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Richard Golnik; Andrea Lehmann; Peter-Michael Kloetzel; Frédéric Ebstein. "Major Histocompatibility Complex (MHC) Class I Processing of the NY-ESO-1 Antigen Is Regulated by Rpn10 and Rpn13 Proteins and Immunoproteasomes following Non-lysine Ubiquitination." The Journal of biological chemistry (2016).

Epitope: NY-ESO-1 157-165
Chemical type: Peptide from protein
Sequence: SLLMWITQC
Position: 157-165
Source molecule (GenBank): P78358.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: NY-ESO-1 157-165
Chemical type: Peptide from protein
Sequence: SLLMWITQC
Position: 157-165
Source molecule (GenBank): P78358.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Kimihiro Ito; Makoto Mitsunaga; Takashi Nishimura; Hisataka Kobayashi; Hisao Tajiri. "Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging." Oncotarget (2016).

Epitope: Epitope of trastuzumab/Herceptin on HER2
Chemical type: Discontinuous protein residues
Discontinuous residues: P579, E580, A581, D582, Q583, D592, P593, P594, F595, K615, F616, P617, D618, E619, E620, G621, A622, C623, Q624, P625
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive
Host: F

Epitope: Epitope of trastuzumab/Herceptin on HER2
Chemical type: Discontinuous protein residues
Discontinuous residues: P579, E580, A581, D582, Q583, D592, P593, P594, F595, K615, F616, P617, D618, E619, E620, G621, A622, C623, Q624, P625
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive-Low
Host: F

Epitope: Epitope of pertuzumab/Perjeta on HER2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q178, H267, F279, T290, V308, S310, T312, P316, L317, H318, K333, P337
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive

Epitope: Epitope of pertuzumab/Perjeta on HER2
Chemical type: Discontinuous protein residues
Discontinuous residues: Q178, H267, F279, T290, V308, S310, T312, P316, L317, H318, K333, P337
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive-Low
Reference: P Hu; Z Wei; R Li; D Wu; Z Meng. "Prediction and preliminary screening of HLA-A*0201-restricted epitope peptides of human GPC3." International journal of immunogenetics (2016).

Epitope: GPC3 (169-177)
Chemical type: Peptide from protein
Sequence: ELFDSLFPV
Position: 169-177
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-Low

Epitope: GPC3 (44-52)
Chemical type: Peptide from protein
Sequence: RLQPGLKWV
Position: 44-52
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-Low

Epitope: GPC3 (326-334)
Chemical type: Peptide from protein
Sequence: TIHDSIQYV
Position: 326-334
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive

Epitope: GPC3 (522-530)
Chemical type: Peptide from protein
Sequence: FLAELAYDL
Position: 522-530
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-Low

Epitope: GPC3 (281-289)
Chemical type: Peptide from protein
Sequence: VMQGCMAGV
Position: 281-289
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-Low

Epitope: GPC3 (155-163)
Chemical type: Peptide from protein
Sequence: YILGSDINV
Position: 155-163
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive

Epitope: GPC3 (319-327)
Chemical type: Peptide from protein
Sequence: VLLGLFSTI
Position: 319-327
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-Low

Epitope: GPC3 (564-572)
Chemical type: Peptide from protein
Sequence: LLTSMAISV
Position: 564-572
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive

Epitope: GPC3 (222-230)
Chemical type: Peptide from protein
Sequence: SLQVTRIFL
Position: 222-230
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-High

Epitope: GPC3 (299-307)
Chemical type: Peptide from protein
Sequence: YILSLEELV
Position: 299-307
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-Low

Epitope: GPC3 (229-237)
Chemical type: Peptide from protein
Sequence: FLQALNLGI
Position: 229-237
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-Low

Epitope: GPC3 (367-375)
Chemical type: Peptide from protein
Sequence: FIDKKVLKV
Position: 367-375
Source molecule (GenBank): P51654.1
Assay category: MhcBinding
Result: Positive-Low
Reference: Gabriela N Chiritoiu; Camilla Jandus; Cristian V A Munteanu; Simona Ghenea; Philippe O Gannon; Pedro Romero; Stefana M Petrescu. "Epitope located N-glycans impair the MHC-I epitope generation and presentation." Electrophoresis (2016).

Epitope: tyrosinase YMD
Chemical type: Peptide from protein
Sequence: YMNGTMSQV
Position: 369-377
Source molecule (GenBank): P14679.3
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: tyrosinase YMD
Chemical type: Peptide from protein
Sequence: YMNGTMSQV
Position: 369-377
Source molecule (GenBank): P14679.3
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: tyrosinase YMD
Chemical type: Peptide from protein
Sequence: YMNGTMSQV
Position: 369-377
Source molecule (GenBank): P14679.3
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: tyrosinase YMD
Chemical type: Peptide from protein
Sequence: YMNGTMSQV
Position: 369-377
Source molecule (GenBank): P14679.3
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: tyrosinase YMD
Chemical type: Peptide from protein
Sequence: YMNGTMSQV
Position: 369-377
Source molecule (GenBank): P14679.3
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: tyrosinase YMD
Chemical type: Peptide from protein
Sequence: YMNGTMSQV
Position: 369-377
Source molecule (GenBank): P14679.3
Assay category: MhcLigandElution
Result: Positive
Reference: Nicholas Paul Casey; Hiroshi Fujiwara; Kazushi Tanimoto; Sachiko Okamoto; Junichi Mineno; Kiyotaka Kuzushima; Hiroshi Shiku; Masaki Yasukawa. "A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy." PloS one (2016).

Epitope: AUK 207-215
Chemical type: Peptide from protein
Sequence: YLILEYAPL
Position: 207-215
Source molecule (GenBank): A3KFJ0
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: AUK 207-215
Chemical type: Peptide from protein
Sequence: YLILEYAPL
Position: 207-215
Source molecule (GenBank): A3KFJ0
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: AUK 207-215
Chemical type: Peptide from protein
Sequence: YLILEYAPL
Position: 207-215
Source molecule (GenBank): A3KFJ0
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: AUK 207-215
Chemical type: Peptide from protein
Sequence: YLILEYAPL
Position: 207-215
Source molecule (GenBank): A3KFJ0
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: AUK 207-215
Chemical type: Peptide from protein
Sequence: YLILEYAPL
Position: 207-215
Source molecule (GenBank): A3KFJ0
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: AUK 207-215
Chemical type: Peptide from protein
Sequence: YLILEYAPL
Position: 207-215
Source molecule (GenBank): A3KFJ0
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered
Reference: E A Mittendorf; A Ardavanis; J Symanowski; J L Murray; N M Shumway; J K Litton; D F Hale; S A Perez; E A Anastasopoulou; N F Pistamaltzian; S Ponniah; C N Baxevanis; E von Hofe; M Papamichail; G E Peoples. "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence." Annals of oncology : official journal of the European Society for Medical Oncology (2016).

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Negative

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: AE36
Chemical type: Peptide from protein
Sequence: GVGSPYVSRLLGICL
Position: 776-790
Source molecule (GenBank): J3QLU9.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: AE36
Chemical type: Peptide from protein
Sequence: GVGSPYVSRLLGICL
Position: 776-790
Source molecule (GenBank): J3QLU9.1
Assay category: TCell
Result: Positive

Epitope: AE36
Chemical type: Peptide from protein
Sequence: GVGSPYVSRLLGICL
Position: 776-790
Source molecule (GenBank): J3QLU9.1
Assay category: TCell
Result: Positive-Low

Epitope: AE36
Chemical type: Peptide from protein
Sequence: GVGSPYVSRLLGICL
Position: 776-790
Source molecule (GenBank): J3QLU9.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: AE36
Chemical type: Peptide from protein
Sequence: GVGSPYVSRLLGICL
Position: 776-790
Source molecule (GenBank): J3QLU9.1
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: AE36
Chemical type: Peptide from protein
Sequence: GVGSPYVSRLLGICL
Position: 776-790
Source molecule (GenBank): J3QLU9.1
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo
Reference: Sabine Schmied; Emma Gostick; David A Price; Hinrich Abken; Mario Assenmacher; Anne Richter. "Analysis of the functional WT1-specific T-cell repertoire in healthy donors reveals a discrepancy between CD4(+) and CD8(+) memory formation." Immunology (2015).

Epitope: WT1 37
Chemical type: Peptide from protein
Sequence: VLDFAPPGA
Position: 37-45
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: WT1 187
Chemical type: Peptide from protein
Sequence: SLGEQQYSV
Position: 187-195
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: WT1 235
Chemical type: Peptide from protein
Sequence: CMTWNQMNL
Position: 235-243
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Hiroyuki Suzuki; Mitsuro Fukuhara; Takumi Yamaura; Satoshi Mutoh; Naoyuki Okabe; Hiroshi Yaginuma; Takeo Hasegawa; Atsushi Yonechi; Jun Osugi; Mika Hoshino; Takashi Kimura; Mitsunori Higuchi; Yutaka Shio; Kazuya Ise; Kazuyoshi Takeda; Mitsukazu Gotoh. "Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer." Journal of translational medicine (2013).

Epitope: TTK-567
Chemical type: Peptide from protein
Sequence: SYRNEIAYL
Position: 567-575
Source molecule (GenBank): P33981.2
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: TTK-567
Chemical type: Peptide from protein
Sequence: SYRNEIAYL
Position: 567-575
Source molecule (GenBank): P33981.2
Assay category: TCell
Result: Positive-High
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: CDCA1-56
Chemical type: Peptide from protein
Sequence: VYGIRLEHF
Position: 56-64
Source molecule (GenBank): B1AQT3
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: CDCA1-56
Chemical type: Peptide from protein
Sequence: VYGIRLEHF
Position: 56-64
Source molecule (GenBank): B1AQT3
Assay category: TCell
Result: Positive-High
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: VEGFR1-770
Chemical type: Peptide from protein
Sequence: TLFWLLLTL
Position: 770-778
Source molecule (GenBank): P17948.2
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: VEGFR1-770
Chemical type: Peptide from protein
Sequence: TLFWLLLTL
Position: 770-778
Source molecule (GenBank): P17948.2
Assay category: TCell
Result: Positive-High
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: VEGFR2-169
Chemical type: Peptide from protein
Sequence: RFVPDGNRI
Position: 169-177
Source molecule (GenBank): P35968.2
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: VEGFR2-169
Chemical type: Peptide from protein
Sequence: RFVPDGNRI
Position: 169-177
Source molecule (GenBank): P35968.2
Assay category: TCell
Result: Positive-High
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Fahmin Basher; Payal Dhar; Xin Wang; Derek A Wainwright; Bin Zhang; Jeffrey Sosman; Zhe Ji; Jennifer D Wu. "Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy." Journal of hematology & oncology (2020).

Epitope: gp100 25-33
Chemical type: Peptide from protein
Sequence: KVPRNQDWL
Position: 25-33
Source molecule (GenBank): AAB31176.1
Assay category: TCell
Result: Positive
Host: M 8-10 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: gp100 25-33
Chemical type: Peptide from protein
Sequence: KVPRNQDWL
Position: 25-33
Source molecule (GenBank): AAB31176.1
Assay category: TCell
Result: Positive
Host: M 8-10 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Xuejun Zhang; Chuan Yu; Jin-Qing Liu; Xue-Feng Bai. "Dendritic cell expression of CD24 contributes to optimal priming of T lymphocytes in lymph nodes." Frontiers in immunology (2023).

Epitope: MOG 35-55
Chemical type: Peptide from protein
Sequence: MEVGWYRSPFSRVVHLYRNGK
Position: 35-55
Source molecule (GenBank): AAA03180.1
Assay category: TCell
Result: Positive
Cell type: T cell
Tissue: lymph node
Culture conditions: In Vivo

Epitope: MOG 35-55
Chemical type: Peptide from protein
Sequence: MEVGWYRSPFSRVVHLYRNGK
Position: 35-55
Source molecule (GenBank): AAA03180.1
Assay category: TCell
Result: Positive

Epitope: MOG 35-55
Chemical type: Peptide from protein
Sequence: MEVGWYRSPFSRVVHLYRNGK
Position: 35-55
Source molecule (GenBank): AAA03180.1
Assay category: TCell
Result: Positive

Epitope: MOG 35-55
Chemical type: Peptide from protein
Sequence: MEVGWYRSPFSRVVHLYRNGK
Position: 35-55
Source molecule (GenBank): AAA03180.1
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: lymph node
Culture conditions: Direct Ex Vivo

Epitope: OVA 323-339
Chemical type: Peptide from protein
Sequence: SQAVHAAHAEINEAGR
Position: 325-340
Source molecule (GenBank): P01012.2
Assay category: TCell
Result: Positive
Cell type: T cell
Tissue: lymph node
Culture conditions: In Vivo

Epitope: MOG 38-49
Chemical type: Peptide from protein
Sequence: GWYRSPFSRVVH
Position: 38-49
Source molecule (GenBank): AAA03180.1
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: lymph node
Culture conditions: Direct Ex Vivo
Reference: Chenwei Wang; Jiewen Chen; Jingyao Li; Zhihong Xu; Lihong Huang; Qian Zhao; Lei Chen; Xiaolong Liang; Hai Hu; Gang Li; Chengjie Xiong; Bin Wu; Hua You; Danyi Du; Xiaoling Wang; Hongle Li; Zibing Wang; Lin Chen. "An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model." The Journal of clinical investigation (2024).

Epitope: EBNA1 564–583
Chemical type: Peptide from protein
Sequence: VFLQTHIFAEVLKDAIKDLV
Position: 564-583
Source molecule (GenBank): Q3KSS4.1
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: EBNA1 567-581
Chemical type: Peptide from protein
Sequence: QTHIFAEVLKDAIKD
Position: 567-581
Source molecule (GenBank): Q3KSS4.1
Assay category: MhcLigandElution
Result: Positive
Reference: Anna Morena D'Alise; Guido Leoni; Gabriella Cotugno; Loredana Siani; Rosa Vitale; Valentino Ruzza; Irene Garzia; Laura Antonucci; Elisa Micarelli; Veronica Venafra; Sven Gogov; Alessia Capone; Sarah Runswick; Juan Martin-Liberal; Emiliano Calvo; Victor Moreno; Stefan N Symeonides; Elisa Scarselli; Oliver Bechter. "Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses." Clinical cancer research : an official journal of the American Association for Cancer Research (2024).

Epitope: NeoAg7
Chemical type: Peptide, no natural source
Sequence: RDLSIFSYL
Assay category: TCell
Result: Positive
Host: M 64 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: NeoAg7
Chemical type: Peptide, no natural source
Sequence: RDLSIFSYL
Assay category: TCell
Result: Positive
Host: M 64 years
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo